What is the appropriate management of lithium toxicity, including indications for hemodialysis and criteria for re‑initiating lithium therapy?

Management of Lithium Toxicity

For severe lithium toxicity with significant neurological symptoms or serum lithium >2.5 mmol/L in chronic toxicity, hemodialysis should be initiated immediately while providing aggressive supportive care, and lithium should not be restarted until the patient has fully recovered and the underlying cause of toxicity has been addressed. 1, 2

Immediate Assessment and Supportive Care

The first priority is stabilization, not identification of the exact lithium level. Treatment must begin before laboratory results return 1. Focus on:

• Airway protection if altered mental status is present
• Intravenous hydration with normal saline to maintain urine output and enhance renal lithium clearance 1, 3
• Discontinue lithium immediately 1
• Stop all interacting medications including NSAIDs, diuretics, ACE inhibitors, and ARBs 4, 5
• Monitor for cardiac arrhythmias and provide continuous cardiac monitoring 2

Classification of Toxicity Type

The type of toxicity determines severity and treatment approach:

• Acute toxicity (single large ingestion in lithium-naive patients): Generally causes milder symptoms despite high serum levels due to limited tissue distribution 6, 3
• Chronic toxicity (accumulation during maintenance therapy): More severe neurological symptoms at lower serum levels due to extensive tissue distribution 2, 6
• Acute-on-chronic toxicity: Most dangerous, combining high tissue burden with additional exposure 2

Critical distinction: Patients with chronic or acute-on-chronic toxicity require more aggressive intervention than those with acute toxicity, even at similar serum concentrations 6.

Indications for Hemodialysis

Hemodialysis is indicated when any of the following are present 2, 6, 3:

1. Severe neurological symptoms (altered consciousness, seizures, severe tremor, coma) regardless of serum level
2. Serum lithium >2.5 mmol/L in chronic toxicity 2
3. Serum lithium >4.0 mmol/L in acute toxicity with symptoms 6
4. Renal failure preventing adequate lithium clearance 1, 3
5. Cardiovascular instability or life-threatening arrhythmias 2

Important Caveat on Acute Toxicity

In acute lithium overdose (lithium-naive patients), even levels >3.5 mmol/L may not require hemodialysis if symptoms are mild, as these patients frequently recover with supportive care alone 6. Ten patients with acute intoxication and levels ≥3.5 mmol/L (mean 5.2 mmol/L) recovered fully without hemodialysis 6.

Hemodialysis vs. Continuous Renal Replacement Therapy

Standard approach: Intermittent hemodialysis is the most efficient method for lithium removal 3, 7

Alternative approach: Continuous renal replacement therapy (CRRT) or continuous hemodialysis should be used when 8, 9:

• Hemodynamic instability or intradialytic hypotension occurs
• Patient requires vasopressors (which increase mortality)
• Severe neurological symptoms make intermittent HD poorly tolerated

CRRT provides gradual lithium removal over >16 hours, avoiding rebound effects and allowing better hemodynamic tolerance 2, 8.

Critical Pitfall: Lithium Rebound

Serum lithium concentrations often rebound 6-12 hours after hemodialysis ends due to redistribution from tissue compartments 2, 7. This requires:

• Repeat serum lithium measurement 4-6 hours post-dialysis 7
• Repeated or prolonged dialysis sessions if rebound is significant 1, 2
• Continue monitoring for 24-48 hours after final dialysis session 7

Monitoring During Treatment

• Serum lithium levels: Every 4-6 hours initially, then every 12 hours until consistently declining 7
• Renal function: Creatinine and BUN to assess kidney recovery 1
• Electrolytes: Sodium depletion worsens toxicity 1
• Neurological status: Serial examinations for improvement or deterioration 6
• Cardiac monitoring: Continuous ECG for arrhythmias 2

Criteria for Re-initiating Lithium Therapy

Lithium should NOT be restarted until 5, 7:

1. Complete resolution of all toxic symptoms, particularly neurological manifestations
2. Serum lithium undetectable or <0.6 mmol/L
3. Underlying precipitant identified and corrected (dehydration, drug interactions, renal impairment)
4. Patient education completed on avoiding future toxicity
5. Monitoring plan established with more frequent serum level checks initially

If lithium is restarted 7:

• Begin at 300 mg three times weekly (if on dialysis) or 300 mg daily (if normal renal function)
• Check serum lithium after 5-7 days, then weekly for one month
• Target therapeutic range 0.6-1.0 mmol/L (lower than traditional 0.8-1.2 mmol/L in high-risk patients) 10

Special Consideration for Dialysis Patients

In patients on chronic dialysis who require lithium for bipolar disorder, lithium remains an option 7. Administer 300-900 mg lithium carbonate three times weekly immediately after dialysis, with pre-dialysis serum levels monitored for at least two weeks after initiation 7.

Key Clinical Pearls

• Chronic toxicity is more dangerous than acute toxicity at equivalent serum levels 6
• Older adults develop toxicity at lower doses (mean 675 mg/day) and therapeutic serum levels 10
• Polypharmacy is present in 63% of toxicity cases 10
• Do not rely solely on serum lithium levels—clinical symptoms guide treatment urgency 6
• Gastric lavage has limited utility as lithium is rapidly absorbed 1